Tryp Therapeutics: An Interview with Jim Gilligan Ph.D.
Over-eating disorders occur when the brain is not providing the patient with a signal to feel full.
According the the Chief Scientific Officer of Tryp Therapeutics (TRYP), psilocybin therapy could be used to correct the malfunctioning neural network while helping patients work through food-related anxiety.
This week, the company got the go-ahead from the FDA to continue its binge eating study, so we’ll soon know if the theory holds true!